Rapport Therapeutics Inc
For the period ended Dec 31, 2024. Filed Mar 11, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 11, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
Our corporate headquarters are located in Boston, Massachusetts, where we lease and occupy approximately 11,000 square feet of office space. Our Boston lease expires in December 2026. We will continue to occupy this space in Boston until the commencement of our sublease of a larger space in Boston, comprised of approximately 15,000 square feet of office space which is expected to commence in June 2025 and will expire in November 2031.
We also lease and occupy approximately 21,000 square feet of office and laboratory space in San Diego, California. We relocated to this space from our prior office and laboratory space in San Diego, California in January 2025. Our new San Diego, California lease will expire in December 2029.
We believe our current and future facilities in Boston and San Diego are sufficient for our needs for the foreseeable future. To meet the future needs of our business, we may lease additional or alternate space, and we believe suitable additional or alternative space will be available in the future on commercially reasonable terms.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.